Although the study was underpowered to show a correlation between MM-302 uptake and progression-free survival, an encouraging trend was observed that would warrant the enrollment of additional patients.
1
—
—
Although the study was underpowered to show a correlation between MM-302 uptake and progression-free survival, an encouraging trend was observed that would warrant the enrollment of additional patients.